| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/11/2006 | EP1179186B1 Method for identifying modulators of interacting proteins |
| 01/11/2006 | EP1156817A4 Controlling protein levels in eucaryotic organisms |
| 01/11/2006 | EP1131315B1 Polyhydroxylated heterocyclic derivatives as anti-coagulants |
| 01/11/2006 | EP1131310B1 Chrystals of 5- 6-(2-fluorobenzyl)oxy-2-naphthyl methyl]-2,4-thiazolidinedione |
| 01/11/2006 | EP1104297B1 Compositions for the treatment of chronic lymphocytic leukemia |
| 01/11/2006 | EP1073749B1 Enhancing immune responses to genetic immunization by using a chemokine |
| 01/11/2006 | EP1056732B1 4-aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases |
| 01/11/2006 | EP1047422B1 Use of histamine for elevating blood histamine levels |
| 01/11/2006 | EP0868519B1 Diagnosis and treatment of aur-1 and/or aur-2 related disorders |
| 01/11/2006 | EP0827412B1 A method for radiolabeling a somatostatin-derived peptide analogue having one disulfide bond with a radioisotope of rhenium, and their therapeutical applications |
| 01/11/2006 | EP0823913B1 Synthesis of the breast tumor-associated antigen defined by monoclonal antibody mbr1 and uses thereof |
| 01/11/2006 | EP0821692B1 Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof |
| 01/11/2006 | CN1720326A Method of strengthening foreign epitope presentation by MHC class I by inhibiting TAP activity |
| 01/11/2006 | CN1720262A Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability |
| 01/11/2006 | CN1720259A Tumor targeting agents and uses thereof |
| 01/11/2006 | CN1720258A Tumor targeting agents and uses thereof |
| 01/11/2006 | CN1720257A Methods of down regulating target gene expression in vivo by introduction of interfering RNA |
| 01/11/2006 | CN1720244A Anthranilic acid amide derivatives and their pharmaceutical use |
| 01/11/2006 | CN1720038A Gabapentin analogues for fibromy algia and other disorders |
| 01/11/2006 | CN1720034A Methods of inducing terminal differentiation |
| 01/11/2006 | CN1720029A Alpha-2-delta ligand to treat lower urinary tract symptoms |
| 01/11/2006 | CN1718590A Poria cocos mycellium glucan sulphate derivative and its preparation method and use |
| 01/11/2006 | CN1718587A Ant CD20 chimeric antibody |
| 01/11/2006 | CN1718573A Heterocyclic compound |
| 01/11/2006 | CN1718241A Buckwheat trypsase inhibitor, expression and application thereof |
| 01/11/2006 | CN1718217A Oral liquor Xiao-Ai-Ping for treating cancer, and its prepn. method |
| 01/11/2006 | CN1718215A Medicine for treating and preventing tumour, and its prepn. method |
| 01/11/2006 | CN1718189A Anticarcinogen composition |
| 01/11/2006 | CN1718184A Neo-garcinolic acid composition having anti-neoplastic activity, prepn. method and use thereof |
| 01/11/2006 | CN1718183A Neo-garcinolic acid prepn. for injection use, prepn. method and use thereof |
| 01/11/2006 | CN1235914C Polysaccharides with antithrombotic activity comprising at least a covalent bono with biotin or a biotin derivative |
| 01/11/2006 | CN1235911C Multiple cytokine-antibody complexes |
| 01/11/2006 | CN1235910C Target-specific cytotoxin chimeric with short-peptide harmone |
| 01/11/2006 | CN1235909C Recombination human interferon alpha 8 polypeptide coding cDNA sequence, preparation method and application |
| 01/11/2006 | CN1235901C Compounds of podophyllotoxins, application and preparation method |
| 01/11/2006 | CN1235900C Thioether substituted imidazoquinolines |
| 01/11/2006 | CN1235882C Aliphatic amino substituted indole quinoline derivatives, their preparation method and pharmaceutical application |
| 01/11/2006 | CN1235627C Oral administration Chinese medicine for treating lung cancer |
| 01/11/2006 | CN1235625C Medicine for treating tumour and leucocythemia |
| 01/11/2006 | CN1235624C Medicine for treating cancer and preparing process thereof |
| 01/11/2006 | CN1235614C Chinese traditional medicine composition for treating digestive system cancer and its preparing method |
| 01/11/2006 | CN1235604C Traditional Chinese medicine for treating cancer |
| 01/11/2006 | CN1235595C Chitin soft capsule and preparing method thereof |
| 01/11/2006 | CN1235587C 9-nitrocamptothecin solid dispersant and preparation method |
| 01/11/2006 | CN1235583C Benzimidazole derivatives as therapeutic agents |
| 01/11/2006 | CN1235580C Total gambogic acid preparation and its preparing method |
| 01/11/2006 | CN1235567C Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 01/10/2006 | US6984720 cytotoxic t lymphocytes; immunology |
| 01/10/2006 | US6984654 Cancer treatments and pharmaceutical compositions therefor |
| 01/10/2006 | US6984653 useful as a growth factor receptor tyrosine kinase HER2 (Human epidermal growth factor receptor-2) inhibitor; for treating cancer |
| 01/10/2006 | US6984651 Piperidine amides as modulators of chemokine receptor activity |
| 01/10/2006 | US6984649 Pyridine derivatives |
| 01/10/2006 | US6984648 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
| 01/10/2006 | US6984647 Antiinflammatory agents; analgesics; antiarthritic agents |
| 01/10/2006 | US6984522 Isolation and use of solid tumor stem cells |
| 01/10/2006 | US6984396 Conjugate having a cleavable linkage for use in a liposome |
| 01/10/2006 | US6984384 A biodrug mixture contains a preheated fusion protein,comprising heat shock protein, glucose-regulated protein and immuogens; antigrowth agents; cancer, tuberculosis infection |
| 01/10/2006 | US6984382 Bifunctional protein, preparation and use |
| 01/10/2006 | CA2381513C Bicyclic-substituted 4-amino-pyridopyrimidine derivatives |
| 01/10/2006 | CA2364178C N-benzenesulfonyl l-proline compounds as bradykinin antagonists |
| 01/10/2006 | CA2351620C Nano-emulsion of 5-aminolevulinic acid |
| 01/10/2006 | CA2327758C (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 01/10/2006 | CA2268157C Acridone derivatives and method of preparation of 8-hydroxy imidazoacridinone derivatives |
| 01/10/2006 | CA2081043C Antitumor vaccines comprising il-6 transfected cells |
| 01/09/2006 | CA2474442A1 Cancer treatment resistance and agents modulating such resistance |
| 01/05/2006 | WO2006002121A2 Compounds and methods for treating seizure and paroxysmal disorders |
| 01/05/2006 | WO2006001035A2 Synergistic liposomal tamoxifen composition for topical application and method of preparing thereof. |
| 01/05/2006 | WO2005103237A9 Method of constructing recombinant herpes simplex virus |
| 01/05/2006 | WO2005009345A3 2-desmethyl ansamycin compounds |
| 01/05/2006 | WO2004071441A3 Compositions and methods to modulate immune and inflammatory responses |
| 01/05/2006 | WO2003087338A3 Her-2 receptor tyrosine kinase molecules and uses thereof |
| 01/05/2006 | WO2003016493A3 Transporters and ion channels |
| 01/05/2006 | US20060004428 Pyrrolo (3,4-c) carbazole and pyrido (2,3-b) pyrrolo (3,4-e) indole derivatives, preparation method and pharmaceutical compositions containing same |
| 01/05/2006 | US20060004104 Use of 5-alkyl substituted 2-arylaminophenylacetic acid derivatives as selective cyclooxygenase-2 inhibitors in the treatment of cancer pain, especially bone cancer pain; for example, 5-methyl-2-(2'-chloro-6'-fluoroanilino)-phenylacetic acid |
| 01/05/2006 | US20060004101 Inhibitor for liver cancer onset and progress |
| 01/05/2006 | US20060004084 (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 01/05/2006 | US20060004080 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof a JNK inhibitors and compositions and methods related thereto |
| 01/05/2006 | US20060004073 Compounds, compositions, and methods |
| 01/05/2006 | US20060004065 5,5,7,9,13-%-Pentamethyl-16-[1-methyl-2-(2-methyl)-1,3-thiazol-4-yl)-ethenyl]-6,6-dioxo-1-ox-a-6 lambda 6-thia-cyclohexadeca-10,13-dien-2-one; epothilones and derivatives; improved properties; anticarcinogenic, -tumor agents |
| 01/05/2006 | US20060004059 Substituted heterocycles for the treatment of diabetes and other diseases |
| 01/05/2006 | US20060004056 Di-aryl-substituted-ethan pyridone pde4 inhibitors |
| 01/05/2006 | US20060004053 Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone |
| 01/05/2006 | US20060004052 Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy |
| 01/05/2006 | US20060004044 3-glyoxylamideindoles for treating cancer |
| 01/05/2006 | US20060004033 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
| 01/05/2006 | US20060004029 Nitrogen-containing aromatic derivatives |
| 01/05/2006 | US20060004025 Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 01/05/2006 | US20060004017 Quinazoline derivatives as angiogenesis inhibitors |
| 01/05/2006 | US20060004014 2-Benzylaminodihydropteridinones, process for their manufacture and use thereof as medicaments |
| 01/05/2006 | US20060004010 Ccr4 antagonist and medical use thereof |
| 01/05/2006 | US20060004000 N-aryl-5-substituted-3-yl-1H-indazole-3-carboxamides; amidation of the 1-protected-1H-indazole-3-carboxylic acid, deblocking; hypotensive agents |
| 01/05/2006 | US20060003997 Substituted benzo[e] [1,4] oxazino [3,2-g] isoindole compounds |
| 01/05/2006 | US20060003994 Pyrrolo[2,1-c][1,4]benzodiazepine-napthalimide conjugates linked through piperazine moiety and process for preparation thereof |
| 01/05/2006 | US20060003987 Compounds and their uses |
| 01/05/2006 | US20060003983 Photosensitizer and method for production thereof |
| 01/05/2006 | US20060003979 Topical compositions of cyclic amides as immunotherapeutic agents |
| 01/05/2006 | US20060003976 Cholesterol/bile acid/bile acid derivative-modified therapeutic drug compounds |
| 01/05/2006 | US20060003975 Combination of an aldosterone receptor antagonist and an HMG CoA reductase inhibitor |
| 01/05/2006 | US20060003973 Use of 2alpha-methyl-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strength |
| 01/05/2006 | US20060003955 Immunostimulatory nucleic acid molecules |